Condition: Melanoma · Non-small Cell Lung Cancer · Squamous Cell Carcinoma (Skin) · Sponsor: AstraZeneca
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
This description comes directly from the study's public registry record.
AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com
Always discuss trial participation with your own doctor first.
| Research Site | Grand Rapids, Michigan, United States | Recruiting |
| Research Site | St Louis, Missouri, United States | Recruiting |
| Research Site | Pittsburgh, Pennsylvania, United States | Recruiting |
| Research Site | Houston, Texas, United States | Recruiting |
| Research Site | San Antonio, Texas, United States | Recruiting |
| Research Site | Fairfax, Virginia, United States | Recruiting |
| Research Site | East Melbourne, Australia | Recruiting |
| Research Site | Chūōku, Japan | Recruiting |
| Research Site | Kashiwa, Japan | Recruiting |
| Research Site | Seoul, South Korea | Recruiting |
| Research Site | Seoul, South Korea | Recruiting |
| Research Site | Seoul, South Korea | Not Yet Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07115043